Scientific Review Board A-E

A - E F - J K - O P - S T - Z
Paul S. Aisen, MD
University of California, San Diego
La Jolla, CA
Larry D. Altstiel, MD, PhD
Pfizer Inc.
Brooklyn, NY

Ottavio Arancio, MD, PhD
Columbia University
New York, NY
Sanjay Asthana, MD
University of Wisconsin Madison Medical School
Madison, WI
Theodore Bashore, PhD
University of Northern Colorado
Greeley, CO
Guriq Basi, PhD
Elan Pharmaceuticals
South San Francisco, CA
Roberta Diaz Brinton, PhD
University of Southern California
Los Angeles, CA
Jerry Buccafusco, PhD
Prime Behavior Testing Laboratories, Inc.
Augusta, GA
Luc Buee, PhD
INSERM U422 (French National Institute for Health and Medical Research)
Lille, France
Robert Butler, MD

International Longevity Center
New York, NY

Anne Cataldo, Ph.D.

McLean Hospital/Harvard Medical School
Belmont, MA

Anthony Cerami, PhD

Warren Pharmaceuticals
Ossining, NY

Thomas Cirrito, Ph.D.

Stemline Therapeutics, Inc.
Long Island City, NY

Mark Cochran, PhD

Biotechnology Business Development
Charlottesville, VA

Greg M. Cole, PhD

VA Medical Center
Sepulveda, CA

Jeffrey L. Cummings, MD

University of California, L.A.
Los Angeles, CA

Sunil David, MD, PhD

University of Kansas
Lawrence, KS

Charles S. DeCarli, MD
University of California, Davis
Sacramento, CA
Matthew DeLisa, PhD

Cornell University
Ithaca, NY

Jack Diamond, PhD

McMaster University
Hamilton, Ontario, Canada

Karen Duff, PhD

Columbia University
New York, NY

Christopher B. Eckman, PhD
Mayo Clinic
Jacksonville Jacksonville, FL
Elizabeth Edgerly, PhD

Alzheimer’s Association
Mountain View, CA

1 out of 3 individuals will be affected by Alzheimer's Disease by the age of 80.

Donate Now

We're doing whatever it takes to find a cure for Alzheimer's Disease. But we can't do it without you. Please give generously today. Learn More

Apply for a Grant

ADDF invites scientists to apply for a grant through its Novel Approaches to Drug Discovery for Alzheimer's Disease research award program. Learn More